Jazz Pharmaceuticals (JAZZ)
Create an Alert
69.61
+0.11 +0.16%
NASDAQ
Jun 18, 5:00PM
BATS Real time
Currency in USD
Jazz Pharmaceuticals Debt to Equity Ratio:
0.3883 for March 31, 2013Jazz Pharmaceuticals Historical Debt to Equity Ratio Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.3883 |
| Dec. 31, 2012 | 0.4074 |
| Sept. 30, 2012 | 0.5218 |
| June 30, 2012 | 0.5628 |
| March 31, 2012 | 0.00 |
| Dec. 31, 2011 | 0.00 |
| Sept. 30, 2011 | 0.00 |
| June 30, 2011 | 0.3612 |
| March 31, 2011 | 0.6775 |
| Dec. 31, 2010 | 1.573 |
| Sept. 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 |
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
JAZZ Debt to Equity Ratio Benchmarks
| Companies | |
|---|---|
| Santarus | 0.0924 |
| Cubist Pharmaceuticals | 0.366 |
| Biogen Idec | 0.1247 |
JAZZ Debt to Equity Ratio Rankings
| Overall |
71st percentile 4765 of 16770 |
| Sector |
61st percentile 541 of 1408 in Healthcare |
| Industry |
55th percentile 200 of 453 in Biotechnology |
JAZZ Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.000 | Sep 2011 |
| Maximum | 1.573 | Dec 2010 |
| Average | 0.4492 |
